NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population.

Journal Title: Pharmacological Reports - Year 2010, Vol 62, Issue 3

Abstract

Traditional (t) non-steroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase (COX)-2 inhibitors (coxibs) are important and efficacious drugs for the management of musculoskeletal symptoms. These drugs have both beneficial and adverse effects due to the inhibition of prostanoids. Although the tNSAID and coxib inhibition of COX-2-dependent prostaglandin (PG)E(2) production is effective in ameliorating symptoms of inflammation and pain, a small but consistent increased risk of myocardial infarction has been detected in association with their use. Convincing evidence suggests that cardiovascular toxicity associated with the administration of these compounds occurs through a common mechanism involving inhibition of COX-2-dependent prostacyclin. The development of biomarkers that predict the impact of NSAIDs on COX-1 and COX-2 activities in vitro, ex vivo and in vivo has been essential to read-out the clinical consequences of the varying degrees of inhibition of the two COX-isozymes in humans. Whole blood assays for COX-1 and COX-2 might be candidates as surrogate end-points of toxicity and efficacy of NSAIDs. Using a biomarker strategy, we have shown that the degree of inhibition of COX-2 and the functional selectivity with which it is achieved are relevant to the level of cardiovascular hazard from NSAIDs and relate to drug potency (exposure). We propose that the assessment of COX-2 in whole blood ex vivo, either alone or in combination with urinary levels of 2,3-dinor-6-keto-PGF(1alpha) a biomarker of prostacyclin biosynthesis in vivo, may represent a valid surrogate end-point to predict cardiovascular risk for functionally selective COX-2 inhibitors.

Authors and Affiliations

Marta Capone, Stefania Tacconelli, Luis Garcia Rodriguez, Paola Patrignani

Keywords

Related Articles

Effects of lipoic acid on spleen oxidative stress after LPS administration.

Background: Bacterial endotoxin (lipopolysaccharide - LPS) is a strong modulator of the immune system that plays a crucial role in the pathogenesis of endotoxic shock. The aim of the study was to investigate the effects...

Effect of rutin on total antioxidant status of rats exposed to cigarette smoke.

Exposure to tobacco smoke impairs the antioxidant defense mechanisms. In female Wistar rats fed on regular rodent chow and supplemented with a flavonoids rutin, Trolox Equivalent Antioxidant Capacity (TEAC) was measured...

Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: Implications for reactive oxygen species.

Type 2 diabetes mellitus is associated with clustering of cardiovascular risk factors that may greatly increase individuals' risk of developing coronary artery disease. Type 2 diabetes is believed to impair coronary func...

Enhancement of the anti-immobility action of antidepressants by risperidone in the forced swimming test in mice.

The aim of the present study was to examine the effect of antidepressants (ADs) belonging to different pharmacological groups and risperidone (an atypical antipsychotic drug), given separately or jointly, on immobility t...

Antidepressant treatments-induced modifications of glutamatergic transmission in rat frontal cortex.

The effects of repeated administration of imipramine, citalopram, tianeptine and zinc hydroaspartate, lasting 7, 14 and 21 days, were studied ex vivo in rat frontal cortical slices prepared 48 h after the last dose of th...

Download PDF file
  • EP ID EP149999
  • DOI -
  • Views 86
  • Downloads 0

How To Cite

Marta Capone, Stefania Tacconelli, Luis Garcia Rodriguez, Paola Patrignani (2010). NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population.. Pharmacological Reports, 62(3), 530-535. https://europub.co.uk/articles/-A-149999